The lack of association between APOL1 HRG and new-onset glomerular disease in the present study follows a recent retrospective cohort study that evaluated risk of any glomerular disease relapse after SARS-CoV-2 vaccination. This evidence concerns the gene APOL1 and glomerular disorder.